{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:30:38Z","timestamp":1788892238985,"version":"build-2803163510"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"FONDECYT","award":["3140395"],"award-info":[{"award-number":["3140395"]}]},{"name":"FONDECYT","award":["1160724"],"award-info":[{"award-number":["1160724"]}]},{"name":"FONDECYT","award":["11160651"],"award-info":[{"award-number":["11160651"]}]},{"name":"PIA\/BASAL","award":["FB0002-2014"],"award-info":[{"award-number":["FB0002-2014"]}]},{"name":"PFB\/BASAL","award":["PFB12\/2007"],"award-info":[{"award-number":["PFB12\/2007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12035-019-01784-6","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T13:03:30Z","timestamp":1573131810000},"page":"1131-1145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Andrographolide Reduces Neuroinflammation and Oxidative Stress in Aged Octodon degus"],"prefix":"10.1007","volume":"57","author":[{"given":"Carolina B.","family":"Lindsay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Zolezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela S.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Cisternas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Bozinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3118-9726","authenticated-orcid":false,"given":"Nibaldo C.","family":"Inestrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"issue":"25","key":"1784_CR1","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.2174\/1381612043383359","volume":"10","author":"M Colombres","year":"2004","unstructured":"Colombres M, Sagal JP, Inestrosa NC (2004) An overview of the current and novel drugs for Alzheimer's disease with particular reference to anti-cholinesterase compounds. Curr Pharm Des 10(25):3121\u20133130","journal-title":"Curr Pharm Des"},{"issue":"2","key":"1784_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.mad.2005.09.018","volume":"127","author":"G Silvestrelli","year":"2006","unstructured":"Silvestrelli G, Lanari A, Parnetti L, Tomassoni D, Amenta F (2006) Treatment of Alzheimer's disease: From pharmacology to a better understanding of disease pathophysiology. Mech Ageing Dev 127(2):148\u2013157. \nhttps:\/\/doi.org\/10.1016\/j.mad.2005.09.018","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"1784_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362(4):329\u2013344. \nhttps:\/\/doi.org\/10.1056\/NEJMra0909142","journal-title":"N Engl J Med"},{"key":"1784_CR4","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch M, Masliah E, Hyman B (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"1784_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"F Brosseron","year":"2014","unstructured":"Brosseron F, Krauthausen M, Kummer M, Heneka MT (2014) Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: A comparative overview. Mol Neurobiol 50(2):534\u2013544. \nhttps:\/\/doi.org\/10.1007\/s12035-014-8657-1","journal-title":"Mol Neurobiol"},{"key":"1784_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fncel.2015.00166","volume":"9","author":"MS Arrazola","year":"2015","unstructured":"Arrazola MS, Silva-Alvarez C, Inestrosa NC (2015) How the Wnt signaling pathway protects from neurodegeneration: The mitochondrial scenario. Front Cell Neurosci 9:166. \nhttps:\/\/doi.org\/10.3389\/fncel.2015.00166","journal-title":"Front Cell Neurosci"},{"key":"1784_CR7","doi-asserted-by":"publisher","first-page":"316523","DOI":"10.1155\/2013\/316523","volume":"2013","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Zhao B (2013) Oxidative stress and the pathogenesis of Alzheimer's disease. Oxidative Med Cell Longev 2013:316523. \nhttps:\/\/doi.org\/10.1155\/2013\/316523","journal-title":"Oxidative Med Cell Longev"},{"issue":"1\u20133","key":"1784_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.brainresrev.2004.07.018","volume":"47","author":"RA Fuentealba","year":"2004","unstructured":"Fuentealba RA, Farias G, Scheu J, Bronfman M, Marzolo MP, Inestrosa NC (2004) Signal transduction during amyloid-beta-peptide neurotoxicity: Role in Alzheimer disease. Brain Res Brain Res Rev 47(1\u20133):275\u2013289. \nhttps:\/\/doi.org\/10.1016\/j.brainresrev.2004.07.018","journal-title":"Brain Res Brain Res Rev"},{"issue":"3","key":"1784_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2174\/156720508784533321","volume":"5","author":"W Cerpa","year":"2008","unstructured":"Cerpa W, Dinamarca MC, Inestrosa NC (2008) Structure-function implications in Alzheimer's disease: Effect of Abeta oligomers at central synapses. Curr Alzheimer Res 5(3):233\u2013243","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"1784_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","volume":"12","author":"R Cacace","year":"2016","unstructured":"Cacace R, Sleegers K, Van Broeckhoven C (2016) Molecular genetics of early-onset Alzheimer's disease revisited. Alzheimers Dement 12(6):733\u2013748. \nhttps:\/\/doi.org\/10.1016\/j.jalz.2016.01.012","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1784_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/bpa.12226","volume":"25","author":"Nibaldo C. Inestrosa","year":"2015","unstructured":"Inestrosa NC, Rios JA, Cisternas P, Tapia-Rojas C, Rivera DS, Braidy N, Zolezzi JM, Godoy JA et al (2015) Age progression of neuropathological markers in the brain of the Chilean rodent Octodon degus, a natural model of Alzheimer's disease. Brain Pathol 25(6):679\u2013691. \nhttps:\/\/doi.org\/10.1111\/bpa.12226","journal-title":"Brain Pathology"},{"issue":"34","key":"1784_CR12","doi-asserted-by":"publisher","first-page":"13835","DOI":"10.1073\/pnas.1201209109","volume":"109","author":"AO Ardiles","year":"2012","unstructured":"Ardiles AO, Tapia-Rojas CC, Mandal M, Alexandre F, Kirkwood A, Inestrosa NC, Palacios AG (2012) Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's disease. Proc Natl Acad Sci U S A 109(34):13835\u201313840. \nhttps:\/\/doi.org\/10.1073\/pnas.1201209109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1784_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.neurobiolaging.2016.06.0","volume":"46","author":"DS Rivera","year":"2016","unstructured":"Rivera DS, Lindsay CB, Codocedo JF, Morel I, Pinto C, Cisternas P, Bozinovic F, Inestrosa NC (2016) Andrographolide recovers cognitive impairment in a natural model of Alzheimer\u2019s disease (Octodon degus). Neurobiol Aging 46:204\u2013220. \nhttps:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.06.0","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1784_CR14","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3233\/JAD-180729","volume":"66","author":"P Cisternas","year":"2018","unstructured":"Cisternas P, Zolezzi JM, Lindsay C, Rivera DS, Martinez A, Bozinovic F, Inestrosa NC (2018) New insights into the spontaneous human Alzheimer's disease-like model Octodon degus: Unraveling amyloid-beta peptide aggregation and age-related amyloid pathology. J Alzheimers Dis 66(3):1145\u20131163. \nhttps:\/\/doi.org\/10.3233\/JAD-180729","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1784_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0944-7113(00)80054-9","volume":"7","author":"A. Panossian","year":"2000","unstructured":"Panossian A, Hovhannisyan A, Mamikonyan G, Abrahamian H, Hambardzumyan E, Gabrielian E, Goukasova G, Wikman G et al (2000) Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human. Phytomedicine 7(5):351\u2013364","journal-title":"Phytomedicine"},{"key":"1784_CR16","doi-asserted-by":"publisher","first-page":"846740","DOI":"10.1155\/2013\/846740","volume":"2013","author":"T Jayakumar","year":"2013","unstructured":"Jayakumar T, Hsieh CY, Lee JJ, Sheu JR (2013) Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive Phytoconstituent Andrographolide. Evid Based Complement Alternat Med 2013:846740. \nhttps:\/\/doi.org\/10.1155\/2013\/846740","journal-title":"Evid Based Complement Alternat Med"},{"key":"1784_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1750-1326-9-61","volume":"9","author":"FG Serrano","year":"2014","unstructured":"Serrano FG, Tapia-Rojas C, Carvajal FJ, Hancke J, Cerpa W, Inestrosa NC (2014) Andrographolide reduces cognitive impairment in young and mature AbetaPPswe\/PS-1 mice. Mol Neurodegener 9:61. \nhttps:\/\/doi.org\/10.1186\/1750-1326-9-61","journal-title":"Mol Neurodegener"},{"key":"1784_CR18","doi-asserted-by":"publisher","first-page":"935403","DOI":"10.1155\/2015\/935403","volume":"2015","author":"L Varela-Nallar","year":"2015","unstructured":"Varela-Nallar L, Arredondo SB, Tapia-Rojas C, Hancke J, Inestrosa NC (2015) Andrographolide stimulates neurogenesis in the adult Hippocampus. Neural Plast 2015:935403. \nhttps:\/\/doi.org\/10.1155\/2015\/935403","journal-title":"Neural Plast"},{"key":"1784_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1644\/10-MAMM-F-355.1","volume":"92","author":"R Sikes","year":"2011","unstructured":"Sikes R, Gannon W (2011) Guidelines of the American Society of Mammalogists for the use of wild mammals in research. J Mammal 92:235\u2013253","journal-title":"J Mammal"},{"issue":"3","key":"1784_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/mp.2009.72","volume":"15","author":"EM Toledo","year":"2010","unstructured":"Toledo EM, Inestrosa NC (2010) Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe\/PSEN1DeltaE9 mouse model of Alzheimer's disease. Mol Psychiatry 15(3):272\u2013285. \nhttps:\/\/doi.org\/10.1038\/mp.2009.72","journal-title":"Mol Psychiatry"},{"issue":"10","key":"1784_CR21","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.4103\/1673-5374.238606","volume":"13","author":"C Tapia-Rojas","year":"2018","unstructured":"Tapia-Rojas C, Inestrosa NC (2018) Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer's disease. Neural Regen Res 13(10):1705\u20131710. \nhttps:\/\/doi.org\/10.4103\/1673-5374.238606","journal-title":"Neural Regen Res"},{"issue":"10","key":"1784_CR22","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/S0168-9525(01)02449-0","volume":"17","author":"Brian J Hock","year":"2001","unstructured":"Hock BJ Jr, Lamb BT (2001) Transgenic mouse models of Alzheimer's disease. Trends Genet 17(10):S7\u2013S12","journal-title":"Trends in Genetics"},{"issue":"2","key":"1784_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00702-011-0731-5","volume":"119","author":"N Braidy","year":"2012","unstructured":"Braidy N, Munoz P, Palacios AG, Castellano-Gonzalez G, Inestrosa NC, Chung RS, Sachdev P, Guillemin GJ (2012) Recent rodent models for Alzheimer's disease: Clinical implications and basic research. J Neural Transm 119(2):173\u2013195. \nhttps:\/\/doi.org\/10.1007\/s00702-011-0731-5","journal-title":"J Neural Transm"},{"issue":"7","key":"1784_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neurobiolaging.2004.09.016","volume":"26","author":"Nibaldo C. Inestrosa","year":"2005","unstructured":"Inestrosa N, Reyes A, Chac\u00f3n M, Cerpa W, Villal\u00f3n A, Montiel J, Merabachvili G, Aldunate R et al (2005) Human-like rodent amyloid-beta-peptide determines Alzheimer pathology in aged wild-type Octodon degu. Neurobiol Aging 26(7):1023\u20131028","journal-title":"Neurobiology of Aging"},{"issue":"4","key":"1784_CR25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.2174\/1567205012666150324181652","volume":"12","author":"Robert Deacon","year":"2015","unstructured":"Deacon RM, Altimiras FJ, Bazan-Leon EA, Pyarasani RD, Nachtigall FM, Santos LS, Tsolaki AG, Pednekar L et al (2015) Natural AD-like neuropathology in Octodon degus: Impaired burrowing and Neuroinflammation. Curr Alzheimer Res 12(4):314\u2013322","journal-title":"Current Alzheimer Research"},{"issue":"9","key":"1784_CR26","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.neurobiolaging.2009.10.008","volume":"32","author":"Thomas van Groen","year":"2011","unstructured":"van Groen T, Kadish I, Popovic N, Popovic M, Caballero-Bleda M, Bano-Otalora B, Vivanco P, Rol MA et al (2011) Age-related brain pathology in Octodon degu: Blood vessel, white matter and Alzheimer-like pathology. Neurobiol Aging 32(9):1651\u20131661. \nhttps:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.10.008","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"1784_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8(2):101\u2013112. \nhttps:\/\/doi.org\/10.1038\/nrm2101","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"1784_CR28","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/jnc.13873","volume":"139","author":"C Tapia-Rojas","year":"2016","unstructured":"Tapia-Rojas C, Burgos PV, Inestrosa NC (2016) Inhibition of Wnt signaling induces amyloidogenic processing of amyloid precursor protein and the production and aggregation of amyloid-beta (Abeta)42 peptides. J Neurochem 139(6):1175\u20131191. \nhttps:\/\/doi.org\/10.1111\/jnc.13873","journal-title":"J Neurochem"},{"issue":"5","key":"1784_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/jnc.13667","volume":"138","author":"K Andreasson","year":"2016","unstructured":"Andreasson K, Bachstetter A, Colonna M, Ginhoux HC, Lamb B (2016) Targeting innate immunity for neurodegenerative disorders of the central nervous system. J Neurochem 138(5):653\u2013693. \nhttps:\/\/doi.org\/10.1111\/jnc.13667","journal-title":"J Neurochem"},{"issue":"9","key":"1784_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1042\/CS20110164","volume":"121","author":"ML Hanke","year":"2011","unstructured":"Hanke ML, Kielian T (2011) Toll-like receptors in health and disease in the brain: Mechanisms and therapeutic potential. Clin Sci (Lond) 121(9):367\u2013387. \nhttps:\/\/doi.org\/10.1042\/CS20110164","journal-title":"Clin Sci (Lond)"},{"key":"1784_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-3-642-00549-7_8","volume":"336","author":"G Landreth","year":"2009","unstructured":"Landreth G, Reed-Geaghan E (2009) Toll-like receptors in Alzheimer's disease. Curr Top Microbiol Immunol 336:137\u2013153. \nhttps:\/\/doi.org\/10.1007\/978-3-642-00549-7_8","journal-title":"Curr Top Microbiol Immunol"},{"key":"1784_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0079-6123(08)61764-1","volume":"94","author":"LF Eng","year":"1992","unstructured":"Eng LF, Yu AC, Lee YL (1992) Astrocytic response to injury. Prog Brain Res 94:353\u2013365","journal-title":"Prog Brain Res"},{"key":"1784_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fimmu.2017.00187","volume":"8","author":"JM Zolezzi","year":"2017","unstructured":"Zolezzi JM, Inestrosa NC (2017) Wnt\/TLR dialog in Neuroinflammation, relevance in Alzheimer's disease. Front Immunol 8:187. \nhttps:\/\/doi.org\/10.3389\/fimmu.2017.00187","journal-title":"Front Immunol"},{"key":"1784_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bbi.2016.07.143","volume":"58","author":"CL McDonald","year":"2016","unstructured":"McDonald CL, Hennessy E, Rubio-Araiz A, Keogh B, McCormack W, McGuirk P, Reilly M, Lynch MA (2016) Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer's disease. Brain Behav Immun 58:191\u2013200. \nhttps:\/\/doi.org\/10.1016\/j.bbi.2016.07.143","journal-title":"Brain Behav Immun"},{"issue":"3","key":"1784_CR35","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.4049\/jimmunol.1101121","volume":"188","author":"Shirong Liu","year":"2011","unstructured":"Liu S, Liu Y, Hao W, Wolf L, Kiliaan AJ, Penke B, Rube CE, Walter J et al (2012) TLR2 is a primary receptor for Alzheimer's amyloid beta peptide to trigger neuroinflammatory activation. J Immunol 188(3):1098\u20131107. \nhttps:\/\/doi.org\/10.4049\/jimmunol.1101121","journal-title":"The Journal of Immunology"},{"issue":"2","key":"1784_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cyto.2004.11.007","volume":"30","author":"LM Bolin","year":"2005","unstructured":"Bolin LM, Zhaung A, Strychkarska-Orczyk I, Nelson E, Huang I, Malit M, Nguyen Q (2005) Differential inflammatory activation of IL-6 (\u2212\/\u2212) astrocytes. Cytokine 30(2):47\u201355. \nhttps:\/\/doi.org\/10.1016\/j.cyto.2004.11.007","journal-title":"Cytokine"},{"issue":"3","key":"1784_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1750-3639.1994.tb00838.x","volume":"4","author":"LF Eng","year":"1994","unstructured":"Eng LF, Ghirnikar RS (1994) GFAP and astrogliosis. Brain Pathol 4(3):229\u2013237","journal-title":"Brain Pathol"},{"issue":"6","key":"1784_CR38","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/13550280290168631","volume":"8","author":"HE Gendelman","year":"2002","unstructured":"Gendelman HE (2002) Neural immunity: Friend or foe? J Neuro-Oncol 8(6):474\u2013479. \nhttps:\/\/doi.org\/10.1080\/13550280290168631","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"1784_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/imm.12309","volume":"143","author":"X Zhou","year":"2014","unstructured":"Zhou X, Li J, Yang W (2014) Calcium\/calmodulin-dependent protein kinase II regulates cyclooxygenase-2 expression and prostaglandin E2 production by activating cAMP-response element-binding protein in rat peritoneal macrophages. Immunology 143(2):287\u2013299. \nhttps:\/\/doi.org\/10.1111\/imm.12309","journal-title":"Immunology"},{"issue":"4","key":"1784_CR40","first-page":"308","volume":"30","author":"CC Chang","year":"2014","unstructured":"Chang CC, Duann YF, Yen TL, Chen YY, Jayakumar T, Ong ET, Sheu JR (2014) Andrographolide, a novel NF-kappaB inhibitor, inhibits vascular smooth muscle cell proliferation and cerebral endothelial cell inflammation. Acta Cardiol Sin 30(4):308\u2013315","journal-title":"Acta Cardiol Sin"},{"issue":"3","key":"1784_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/01.wco.0000169752.54191.97","volume":"18","author":"L Minghetti","year":"2005","unstructured":"Minghetti L (2005) Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 18(3):315\u2013321","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"1784_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.bjp.0702073","volume":"125","author":"WF Chiou","year":"1998","unstructured":"Chiou WF, Lin JJ, Chen CF (1998) Andrographolide suppresses the expression of inducible nitric oxide synthase in macrophage and restores the vasoconstriction in rat aorta treated with lipopolysaccharide. Br J Pharmacol 125(2):327\u2013334. \nhttps:\/\/doi.org\/10.1038\/sj.bjp.0702073","journal-title":"Br J Pharmacol"},{"key":"1784_CR43","unstructured":"Hidalgo MA, Hancke JL, Bertoglio JC, Burgos R (2013) Andrographolide a new potential drug for the long term treatment of rheumatoid arthritis disease. In: Hiroaki M (ed) Innovative Rheumatology First Edn. IntehOpen Limited, London"},{"issue":"2","key":"1784_CR44","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/sj.bjp.0704493","volume":"135","author":"YC Shen","year":"2002","unstructured":"Shen YC, Chen CF, Chiou WF (2002) Andrographolide prevents oxygen radical production by human neutrophils: Possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol 135(2):399\u2013406. \nhttps:\/\/doi.org\/10.1038\/sj.bjp.0704493","journal-title":"Br J Pharmacol"},{"issue":"11","key":"1784_CR45","doi-asserted-by":"publisher","first-page":"e113148","DOI":"10.1371\/journal.pone.0113148","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang X, Ye P, Cao R, Yang X, Xiao W, Zhang Y, Bai Y, Wu H (2014) The association of homocysteine with metabolic syndrome in a community-dwelling population: Homocysteine might be concomitant with metabolic syndrome. PLoS One 9(11):e113148. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0113148","journal-title":"PLoS One"},{"issue":"1","key":"1784_CR46","first-page":"55","volume":"49","author":"IM Cojocaru","year":"2011","unstructured":"Cojocaru IM, Cojocaru M, Miu G, Sapira V (2011) Study of interleukin-6 production in Alzheimer's disease. Rom J Intern Med 49(1):55\u201358","journal-title":"Rom J Intern Med"},{"key":"1784_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12974-016-0498-6","volume":"13","author":"SY Wong","year":"2016","unstructured":"Wong SY, Tan MG, Banks WA, Wong WS, Wong PT, Lai MK (2016) Andrographolide attenuates LPS-stimulated up-regulation of C-C and C-X-C motif chemokines in rodent cortex and primary astrocytes. J Neuroinflammation 13:34. \nhttps:\/\/doi.org\/10.1186\/s12974-016-0498-6","journal-title":"J Neuroinflammation"},{"issue":"6","key":"1784_CR48","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2174\/18715273113126660170","volume":"12","author":"DK Kaushik","year":"2013","unstructured":"Kaushik DK, Basu A (2013) A friend in need may not be a friend indeed: Role of microglia in neurodegenerative diseases. CNS Neurol Disord Drug Targets 12(6):726\u2013740","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"4","key":"1784_CR49","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bcp.2014.01.008","volume":"88","author":"KI Mosher","year":"2014","unstructured":"Mosher KI, Wyss-Coray T (2014) Microglial dysfunction in brain aging and Alzheimer's disease. Biochem Pharmacol 88(4):594\u2013604. \nhttps:\/\/doi.org\/10.1016\/j.bcp.2014.01.008","journal-title":"Biochem Pharmacol"},{"key":"1784_CR50","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbi.2012.11.011","volume":"31","author":"B.J. Rawdin","year":"2013","unstructured":"Rawdin BJ, Mellon SH, Dhabhar FS, Epel ES, Puterman E, Su Y, Burke HM, Reus VI et al (2013) Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun 31:143\u2013152. \nhttps:\/\/doi.org\/10.1016\/j.bbi.2012.11.011","journal-title":"Brain, Behavior, and Immunity"},{"issue":"6","key":"1784_CR51","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0301-0082(00)00015-0","volume":"62","author":"S Miranda","year":"2000","unstructured":"Miranda S, Opazo C, Larrondo LF, Munoz FJ, Ruiz F, Leighton F, Inestrosa NC (2000) The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease. Prog Neurobiol 62(6):633\u2013648","journal-title":"Prog Neurobiol"},{"issue":"11","key":"1784_CR52","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","volume":"32","author":"DA Butterfield","year":"2002","unstructured":"Butterfield DA, Lauderback CM (2002) Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 32(11):1050\u20131060","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1784_CR53","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5607\/en.2013.22.2.84","volume":"22","author":"JE Lee","year":"2013","unstructured":"Lee JE, Han PL (2013) An update of animal models of Alzheimer disease with a reevaluation of plaque depositions. Exp Neurobiol 22(2):84\u201395. \nhttps:\/\/doi.org\/10.5607\/en.2013.22.2.84","journal-title":"Exp Neurobiol"},{"issue":"3","key":"1784_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.mcna.2012.12.017","volume":"97","author":"CC Rowe","year":"2013","unstructured":"Rowe CC, Villemagne VL (2013) Amyloid imaging with PET in early Alzheimer disease diagnosis. Med Clin North Am 97(3):377\u2013398. \nhttps:\/\/doi.org\/10.1016\/j.mcna.2012.12.017","journal-title":"Med Clin North Am"},{"issue":"3","key":"1784_CR55","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00705-016-3130-2","volume":"162","author":"Zhenguang Li","year":"2016","unstructured":"Li Z, Xu X, Leng X, He M, Wang J, Cheng S, Wu H (2016) Roles of reactive oxygen species in cell signaling pathways and immune responses to viral infections. Arch Virol 162(3):603\u2013610. \nhttps:\/\/doi.org\/10.1007\/s00705-016-3130-2","journal-title":"Archives of Virology"},{"issue":"9","key":"1784_CR56","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.freeradbiomed.2010.01.006","volume":"48","author":"R Gill","year":"2010","unstructured":"Gill R, Tsung A, Billiar T (2010) Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med 48(9):1121\u20131132. \nhttps:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.01.006","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"1784_CR57","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/j.bbamcr.2016.09.003","volume":"1863","author":"D Kim","year":"2016","unstructured":"Kim D, Lee K, Gabr A, Choi G, Kim J, Ko S, Han H (2016) A\u03b2-induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis. Biochim Biophys Acta 1863(11):2820\u20132834. \nhttps:\/\/doi.org\/10.1016\/j.bbamcr.2016.09.003","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"1784_CR58","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1046\/j.1471-4159.1997.69052048.x","volume":"69","author":"G Forloni","year":"1997","unstructured":"Forloni G, Lucca E, Angeretti N, Della Torre P, Salmona M (1997) Amidation of beta-amyloid peptide strongly reduced the amyloidogenic activity without alteration of the neurotoxicity. J Neurochem 69(5):2048\u20132054","journal-title":"J Neurochem"},{"issue":"5","key":"1784_CR59","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0197-4580(01)00340-2","volume":"23","author":"DA Butterfield","year":"2002","unstructured":"Butterfield DA, Castegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23(5):655\u2013664","journal-title":"Neurobiol Aging"},{"issue":"8","key":"1784_CR60","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1089\/ars.2012.5027","volume":"19","author":"DA Butterfield","year":"2013","unstructured":"Butterfield DA, Swomley AM, Sultana R (2013) Amyloid beta-peptide (1-42)-induced oxidative stress in Alzheimer disease: Importance in disease pathogenesis and progression. Antioxid Redox Signal 19(8):823\u2013835. \nhttps:\/\/doi.org\/10.1089\/ars.2012.5027","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"1784_CR61","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tips.2008.09.001","volume":"29","author":"D Pratico","year":"2008","unstructured":"Pratico D (2008) Oxidative stress hypothesis in Alzheimer's disease: A reappraisal. Trends Pharmacol Sci 29(12):609\u2013615. \nhttps:\/\/doi.org\/10.1016\/j.tips.2008.09.001","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"1784_CR62","first-page":"401","volume":"25","author":"M Padurariu","year":"2013","unstructured":"Padurariu M, Ciobica A, Lefter R, Serban IL, Stefanescu C, Chirita R (2013) The oxidative stress hypothesis in Alzheimer's disease. Psychiatr Danub 25(4):401\u2013409","journal-title":"Psychiatr Danub"},{"issue":"8","key":"1784_CR63","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.bbadis.2013.09.015","volume":"1842","author":"AM Swomley","year":"2014","unstructured":"Swomley AM, Forster S, Keeney JT, Triplett J, Zhang Z, Sultana R, Butterfield DA (2014) Abeta, oxidative stress in Alzheimer disease: Evidence based on proteomics studies. Biochim Biophys Acta 1842(8):1248\u20131257. \nhttps:\/\/doi.org\/10.1016\/j.bbadis.2013.09.015","journal-title":"Biochim Biophys Acta"},{"key":"1784_CR64","doi-asserted-by":"crossref","unstructured":"Gemma C, Vila J, Bachstetter A, Bickford PC (2007) Oxidative stress and the aging brain: From theory to prevention. In DR Riddle (ed) Brain aging: Models, methods, and mechanisms, CRC Press\/Taylor & Francis, Boca Rat\u00f3n","DOI":"10.1201\/9781420005523-15"},{"issue":"12","key":"1784_CR65","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.freeradbiomed.2010.02.016","volume":"48","author":"MA Bradley","year":"2010","unstructured":"Bradley MA, Markesbery WR, Lovell MA (2010) Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med 48(12):1570\u20131576. \nhttps:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.02.016","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"1784_CR66","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1440-1681.2012.05723.x","volume":"39","author":"T Sasaoka","year":"2012","unstructured":"Sasaoka T (2012) Oxidative stress in neurodegenerative diseases: Friend and foe. Clin Exp Pharmacol Physiol 39(7):597\u2013598. \nhttps:\/\/doi.org\/10.1111\/j.1440-1681.2012.05723.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"1784_CR67","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1021\/tx9501445","volume":"9","author":"JS Beckman","year":"1996","unstructured":"Beckman JS (1996) Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9(5):836\u2013844. \nhttps:\/\/doi.org\/10.1021\/tx9501445","journal-title":"Chem Res Toxicol"},{"issue":"10","key":"1784_CR68","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00210-019-01672-9","volume":"392","author":"Da-Peng Wang","year":"2019","unstructured":"Wang DP, Yin H, Lin Q, Fang SP, Shen JH, Wu YF, Su SH, Hai J (2019) Andrographolide enhances hippocampal BDNF signaling and suppresses neuronal apoptosis, astroglial activation, neuroinflammation, and spatial memory deficits in a rat model of chronic cerebral hypoperfusion. Naunyn Schmiedeberg's Arch Pharmacol 392:1277\u20131284. \nhttps:\/\/doi.org\/10.1007\/s00210-019-01672-9","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"2","key":"1784_CR69","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1042\/BJ20140207","volume":"466","author":"C Tapia-Rojas","year":"2015","unstructured":"Tapia-Rojas C, Schuller A, Lindsay CB, Ureta RC, Mejias-Reyes C, Hancke J, Melo F, Inestrosa NC (2015) Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3beta: Autoregulation of GSK-3beta in vivo. Biochem J 466(2):415\u2013430. \nhttps:\/\/doi.org\/10.1042\/BJ20140207","journal-title":"Biochem J"},{"issue":"4","key":"1784_CR70","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/jnc.14278","volume":"144","author":"C Tapia-Rojas","year":"2018","unstructured":"Tapia-Rojas C, Inestrosa NC (2018) Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice. J Neurochem 144(4):443\u2013465. \nhttps:\/\/doi.org\/10.1111\/jnc.14278","journal-title":"J Neurochem"},{"key":"1784_CR71","doi-asserted-by":"publisher","unstructured":"Cisternas P, Oliva CA, Torres VI, Barrera DP, Inestrosa NC (2019) Presymptomatic treatment with Andrographolide improves brain metabolic markers and cognitive behavior in a model of early-onset Alzheimer\u2019s disease. Front Cell Neurosci. \nhttps:\/\/doi.org\/10.3389\/fncel.2019.00295","DOI":"10.3389\/fncel.2019.00295"},{"key":"1784_CR72","doi-asserted-by":"publisher","first-page":"109078","DOI":"10.1016\/j.biopha.2019.109078","volume":"117","author":"Jiashu Lu","year":"2019","unstructured":"Lu J, Ma Y, Wu J, Huang H, Wang X, Chen Z, Chen J, He H et al (2019) A review for the neuroprotective effects of andrographolide in the central nervous system. Biomed Pharmacother 117:109078. \nhttps:\/\/doi.org\/10.1016\/j.biopha.2019.109078","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2\u20133","key":"1784_CR73","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ejphar.2008.11.011","volume":"602","author":"MD Carretta","year":"2009","unstructured":"Carretta MD, Alarcon P, Jara E, Solis L, Hancke JL, Concha II, Hidalgo MA, Burgos RA (2009) Andrographolide reduces IL-2 production in T-cells by interfering with NFAT and MAPK activation. Eur J Pharmacol 602(2\u20133):413\u2013421. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2008.11.011","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"1784_CR74","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1021\/np200631v","volume":"74","author":"Haw-Wen Chen","year":"2011","unstructured":"Chen HW, Lin AH, Chu HC, Li CC, Tsai CW, Chao CY, Wang CJ, Lii CK et al (2011) Inhibition of TNF-alpha-induced inflammation by andrographolide via down-regulation of the PI3K\/Akt signaling pathway. J Nat Prod 74(11):2408\u20132413. \nhttps:\/\/doi.org\/10.1021\/np200631v","journal-title":"Journal of Natural Products"},{"issue":"3","key":"1784_CR75","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.apsb.2016.02.002","volume":"6","author":"S Peng","year":"2016","unstructured":"Peng S, Hang N, Liu W, Guo W, Jiang C, Yang X, Xu Q, Sun Y (2016) Andrographolide sulfonate ameliorates lipopolysaccharide-induced acute lung injury in mice by down-regulating MAPK and NF-kappaB pathways. Acta Pharm Sin B 6(3):205\u2013211. \nhttps:\/\/doi.org\/10.1016\/j.apsb.2016.02.002","journal-title":"Acta Pharm Sin B"},{"key":"1784_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/3271451","volume":"2016","author":"Janis Ya-Xian Zhan","year":"2016","unstructured":"Zhan JY, Wang XF, Liu YH, Zhang ZB, Wang L, Chen JN, Huang S, Zeng HF et al (2016) Andrographolide sodium bisulfate prevents UV-induced skin Photoaging through inhibiting oxidative stress and inflammation. Mediat Inflamm 2016:3271451. \nhttps:\/\/doi.org\/10.1155\/2016\/3271451","journal-title":"Mediators of Inflammation"},{"key":"1784_CR77","doi-asserted-by":"publisher","first-page":"952375","DOI":"10.1155\/2013\/952375","volume":"2013","author":"SV More","year":"2013","unstructured":"More SV, Kumar H, Kim IS, Song SY, Choi DK (2013) Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease. Mediat Inflamm 2013:952375. \nhttps:\/\/doi.org\/10.1155\/2013\/952375","journal-title":"Mediat Inflamm"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01784-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01784-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01784-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:28:15Z","timestamp":1604622495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01784-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1784"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01784-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"assertion":[{"value":"14 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}